[ad_1]
Pfizer is expected to comment on October 27, 2020 on business results for the quarter ended September 30, 2020.
An average of 13 analysts estimate that in the last quarter there were earnings of $ 0.693 per share. That would be less than 7.60 percent compared to EPS the previous quarter, when it reached $ 0.750 per share.
10 analysts expect an average of 7.15 percent in sales compared to sales of $ 12.68 billion generated in the same quarter last year. Consequently, experts assume an average turnover of 11.77 billion dollars during the last quarter.
Looking at the current fiscal year, 13 analysts are expecting earnings per share of $ 2.72 on average, compared with $ 2.95 in the prior year. In terms of sales, 10 analysts assume on average that a total of $ 48.93 billion will be converted in the current fiscal year, compared to $ 51.75 billion a year earlier.
Editors of Finanzen.at
